サマリー

世界の遺伝子治療市場 2022-2026
Technavioは遺伝子治療市場を監視しており、2022-2026年の間に40億2000万ドルの成長が見込まれ、予測期間中に19.84%のCAGRで進行しています。当レポートでは、遺伝子治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、特効薬指定の増加、遺伝子治療に関連する利益、老年人口の増加によって牽引されています。
遺伝子治療市場の分析には、治療分野セグメントと地理的展望が含まれます。
Technavioの遺伝子治療市場は、以下のように区分されています。
治療分野別
- オンコロジー
- 中枢神経系
- 眼科
- 希少疾患
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における遺伝子治療市場の成長を促進する主な要因の1つとして、CVDや希少疾患に対する遺伝子治療の研究が拡大していることを挙げています。また、パートナーシップやコラボレーションが市場のシナリオを変化させており、発展途上国の急速な成長の可能性が市場の大きな需要につながると考えています。
Technavio社は、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。当社の遺伝子治療市場に関するレポートは、以下の分野をカバーしています。
- 遺伝子治療市場のサイジング
- 遺伝子治療市場の予測
- 遺伝子治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abeona Therapeutics Inc.、Adaptimmune Therapeutics plc、Adverum Biotechnologies Inc.を含むいくつかの主要遺伝子治療市場ベンダーについて詳細に分析しています。Applied Genetic Technologies Corp.、Amgen Inc.、Astellas Pharma Inc.、Biogen Inc.、bluebird bio Inc.、Editas Medicine Inc.、ElevateBio、F. Hoffmann La Roche Ltd.、Generation Bio、Gilead Sciences Inc. 、Novartis AG、Orchard Therapeutics Plc、Poseida Therapeutics Inc、Sangamo Therapeutics Inc.、Sibiono GeneTech Co.Ltd.、uniQure NV、およびVoyager Therapeutics Inc.です。また、遺伝子治療市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gene-therapy-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Therapy Area
o 5.1 Market segments
o Exhibit 24: Chart on Therapy Area - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Therapy Area - Market share 2021-2026 (%)
o 5.2 Comparison by Therapy Area
o Exhibit 26: Chart on Comparison by Therapy Area
o Exhibit 27: Data Table on Comparison by Therapy Area
o 5.3 Oncology - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
o 5.4 CNS - Market size and forecast 2021-2026
o Exhibit 32: Chart on CNS - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on CNS - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on CNS - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on CNS - Year-over-year growth 2021-2026 (%)
o 5.5 Opthalmology - Market size and forecast 2021-2026
o Exhibit 36: Chart on Opthalmology - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Opthalmology - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Opthalmology - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Opthalmology - Year-over-year growth 2021-2026 (%)
o 5.6 Rare diseases - Market size and forecast 2021-2026
o Exhibit 40: Chart on Rare diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Rare diseases - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Rare diseases - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Rare diseases - Year-over-year growth 2021-2026 (%)
o 5.7 Others - Market size and forecast 2021-2026
o Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Therapy Area
o Exhibit 48: Market opportunity by Therapy Area ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abeona Therapeutics Inc.
o Exhibit 97: Abeona Therapeutics Inc. - Overview
o Exhibit 98: Abeona Therapeutics Inc. - Product / Service
o Exhibit 99: Abeona Therapeutics Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 100: Amgen Inc. - Overview
o Exhibit 101: Amgen Inc. - Product / Service
o Exhibit 102: Amgen Inc. - Key offerings
o 10.5 Biogen Inc.
o Exhibit 103: Biogen Inc. - Overview
o Exhibit 104: Biogen Inc. - Product / Service
o Exhibit 105: Biogen Inc. - Key offerings
o 10.6 bluebird bio Inc.
o Exhibit 106: bluebird bio Inc. - Overview
o Exhibit 107: bluebird bio Inc. - Product / Service
o Exhibit 108: bluebird bio Inc. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Gilead Sciences Inc.
o Exhibit 114: Gilead Sciences Inc. - Overview
o Exhibit 115: Gilead Sciences Inc. - Product / Service
o Exhibit 116: Gilead Sciences Inc. - Key news
o Exhibit 117: Gilead Sciences Inc. - Key offerings
o 10.9 Novartis AG
o Exhibit 118: Novartis AG - Overview
o Exhibit 119: Novartis AG - Business segments
o Exhibit 120: Novartis AG - Key offerings
o Exhibit 121: Novartis AG - Segment focus
o 10.10 Orchard Therapeutics Plc
o Exhibit 122: Orchard Therapeutics Plc - Overview
o Exhibit 123: Orchard Therapeutics Plc - Product / Service
o Exhibit 124: Orchard Therapeutics Plc - Key offerings
o 10.11 Sibiono GeneTech Co. Ltd.
o Exhibit 125: Sibiono GeneTech Co. Ltd. - Overview
o Exhibit 126: Sibiono GeneTech Co. Ltd. - Product / Service
o Exhibit 127: Sibiono GeneTech Co. Ltd. - Key offerings
o 10.12 uniQure NV
o Exhibit 128: uniQure NV - Overview
o Exhibit 129: uniQure NV - Product / Service
o Exhibit 130: uniQure NV - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy Area - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy Area - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy Area
Exhibits27: Data Table on Comparison by Therapy Area
Exhibits28: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on CNS - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on CNS - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on CNS - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on CNS - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Opthalmology - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Opthalmology - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Opthalmology - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Opthalmology - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Rare diseases - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Rare diseases - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Rare diseases - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Rare diseases - Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Therapy Area ($ million)
Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abeona Therapeutics Inc. - Overview
Exhibits98: Abeona Therapeutics Inc. - Product / Service
Exhibits99: Abeona Therapeutics Inc. - Key offerings
Exhibits100: Amgen Inc. - Overview
Exhibits101: Amgen Inc. - Product / Service
Exhibits102: Amgen Inc. - Key offerings
Exhibits103: Biogen Inc. - Overview
Exhibits104: Biogen Inc. - Product / Service
Exhibits105: Biogen Inc. - Key offerings
Exhibits106: bluebird bio Inc. - Overview
Exhibits107: bluebird bio Inc. - Product / Service
Exhibits108: bluebird bio Inc. - Key offerings
Exhibits109: F. Hoffmann La Roche Ltd. - Overview
Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
Exhibits111: F. Hoffmann La Roche Ltd. - Key news
Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits114: Gilead Sciences Inc. - Overview
Exhibits115: Gilead Sciences Inc. - Product / Service
Exhibits116: Gilead Sciences Inc. - Key news
Exhibits117: Gilead Sciences Inc. - Key offerings
Exhibits118: Novartis AG - Overview
Exhibits119: Novartis AG - Business segments
Exhibits120: Novartis AG - Key offerings
Exhibits121: Novartis AG - Segment focus
Exhibits122: Orchard Therapeutics Plc - Overview
Exhibits123: Orchard Therapeutics Plc - Product / Service
Exhibits124: Orchard Therapeutics Plc - Key offerings
Exhibits125: Sibiono GeneTech Co. Ltd. - Overview
Exhibits126: Sibiono GeneTech Co. Ltd. - Product / Service
Exhibits127: Sibiono GeneTech Co. Ltd. - Key offerings
Exhibits128: uniQure NV - Overview
Exhibits129: uniQure NV - Product / Service
Exhibits130: uniQure NV - Key offerings
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations